Results From Trial Support Expanding Approval of Defibrillators

According to Millennium Research Group … growth in the $2 billion U.S. cardiac resynchronization therapy defibrillator market will be supported by the expanded approval of Boston Scientific’s chronic resynchronization therapy defibrillators in New York Heart Association class I and II patients.
Triangle Business Journal